Federico Asch, ESC 2019 – the WASE Normal Values Study
We spoke to Dr Federico Asch (MedStar Health Research Institute, Washington Hospital Center, Washington, DC, USA) about the World Alliance of Societies of Echocardiography (WASE) Normal Values Study, and the difficulties of applying these results worldwide. He discusses the racial and national differences in cardiac chamber size and function, and how this may affect routine practice.
Speaker’s Disclosures: Federico Asch has nothing to declare in relation to this video interview. The WASE study was sponsored by the American Society of Echocardiography, with in-kind donations from MedStar Health, the University of Chicago, TOMTEC and MEDIDATA.
1. What was the rationale for, and the results of, the World Alliance of Societies of Echocardiography (WASE) Normal Values Study? (0:04)
2. What were the most notable similarities and differences in cardiac chamber size and function between races and nationalities? (1:21)
3. How can these findings help physicians optimise management strategies for patients in routine practice? (2:21)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the European Society of Cardiology (ESC) Congress 2019 in Paris, France, September 2019.
Share this Video
Related Videos In Cardiovascular Disease
John Forrest, ACC 2023: Evolut low risk trial, transcatheter versus surgical aortic valve replacement in patients at low surgical risk
The Evolut low risk trial aimed to compare transcatheter versus surgical aortic valve replacement in patients who were at low risk for surgery. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to discuss the eligibility criteria, the key findings and the outlook for […]
John Forrest, ACC 2023: The treatment paradigm for patients with aortic stenosis
The treatment paradigm for aortic stenosis has developed dramatically in the past decade. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to outline and discuss the developments. Dr Forrest presented an abstract entitled ‘Transcatheter Versus Surgical Aortic Valve Replacement In Aortic Stenosis Patients […]
Steven Nissen, ACC 2023: Lipid-lowering therapies – current and future options
Many lipid-lowering therapies exist, such as statins to manage and reduce lipid levels. While statins are the most commonly used medication, some patients may need additional interventions to lower their LDL cholesterol levels. In this touchCARDIO interview, we speak with Prof. Steven Nissen (Cleveland Clinic, Cleveland, OH, USA) to explore current and developing novel lipid-lowering […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!